Articles
Articles and analyses from the INET community on the key economic questions of our time.
Is Silicon Valley Nudging Us Towards an Authoritarian Future?
Margaret Heffernan’s new book “Uncharted” warns against giving up the power to shape our destiny to gurus and gadgets promising false certainty.
Immaculate Deception
Elites Have Made the American Dream a Nightmare for Black People. Who’s Next?
Researchers reveal the enemies to stability and prosperity that threaten us all.
Big Pharma Wants to Pocket the Profits From a COVID Treatment You Already Paid For
Gilead’s shareholders want exorbitant profits from Remdesivir, even though it was the public that enabled its development.
Felwine Sarr: The COVID-19 crisis demonstrates the need to change track and re-think the world of tomorrow.
An interview with Professor Felwine Sarr, Professor of Economics at the Université Gaston Berger of Saint-Louis in Senegal, for INET’s series on COVID-19 and Africa
How the Disappearance of Unionized Jobs Obliterated an Emergent Black Middle Class
Since the 1980s, the enemy of equal employment opportunity through upward socioeconomic mobility has been the pervasive and entrenched corporate-governance ideology and practice of maximizing shareholder value.
Benno Ndulu: The pandemic has laid bare the pivotal roles of both the informal sector and SMEs
Enhancing Resilience in African Economies: Policy Responses to the COVID19 Pandemic in Africa
From Eric Garner to George Floyd: How History Repeats Itself
The Great Migration brought many freedmen to the North, and the reaction to that brought the Southern Mind to northern police officers as well.
COVID-19 Cases and Deaths Surge: The Impact of Wisconsin’s In-person Primary Vote
The world is on edge at the prospect of a resurgent wave of infections. Models and speculation are rife, but facts remain scarce, which is why the events in Wisconsin on April 7, and their eventual impact, are so important.
Chile’s Outburst of Discontent
Think Big Pharma Won’t Profiteer in the Race to Treat Coronavirus? Think Again.
Evidence shows pharmaceutical companies won’t stop price-gouging and risking American lives for financial gain in this time of crises – unless we force them.
In Italy and Elsewhere, Expansionary Public Spending is Key to Recovery from Covid-19
Austerity policies will slow recovery and should be rejected